📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Mechanism-based heparanase inhibitors reduce cancer metastasis in vivo. (2022)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1073/pnas.2203167119

PubMed Identifier: 35881786

Publication URI: http://europepmc.org/abstract/MED/35881786

Type: Journal Article/Review

Volume: 119

Parent Publication: Proceedings of the National Academy of Sciences of the United States of America

Issue: 31

ISSN: 0027-8424